Tokyo, Jan. 7 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060271) titled 'Molecular subtyping of autism spectrum disorder using blood DNA methylation' on Jan. 6.
Study Type:
Observational
Primary Sponsor:
Institute - National Center of Neurology and Psychiatry
Condition:
Condition - Autism spectrum disorder
Classification by malignancy - Others
Genomic information - YES
Objective:
Narrative objectives1 - The objective of this study is to identify molecular subtypes of autism spectrum disorder using blood DNA methylation analysis and to characterize their biological features.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 4
years-old
=
Gender - Male and Female
Key inclusion c...